Radcliffe Capital Management’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-466,487
| Closed | -$4.63M | – | 905 |
|
|
2022
Q3 | $4.63M | Buy |
466,487
+50,400
| +12% | +$500K | 0.11% | 303 |
|
|
2022
Q2 | $4.1M | Buy |
416,087
+2,400
| +0.6% | +$23.6K | 0.09% | 350 |
|
|
2022
Q1 | $4.05M | Hold |
413,687
| – | – | 0.09% | 325 |
|
|
2021
Q4 | $4.09M | Hold |
413,687
| – | – | 0.11% | 252 |
|
|
2021
Q3 | $4.11M | Sell |
413,687
-897
| -0.2% | -$8.91K | 0.12% | 221 |
|
|
2021
Q2 | $4.02M | Hold |
414,584
| – | – | 0.13% | 234 |
|
|
2021
Q1 | $4.01M | Buy |
+414,584
| New | +$4.01M | 0.16% | 228 |
|